AI-Powered Real-Time Effectiveness Assessment Framework for Cross-Channel Pharmaceutical Marketing: Optimizing ROI through Predictive Analytics

This paper puts forward a new AI-powered real-time efficacy appraisal framework for cross-channel pharmaceutical marketing that deals with the challenges generated by data islands, regulatory constraints, and ROI optimization. This framework combines batch and anti-processing capabilities in a lambda structure to take multi-dimensional data flows from diverse marketing channels so that, with minimal latency, all-round performance analysis is feasible. State-of-the-art technologies drawn from machine learning e.g., attention-based BiLSTM models and semantics network analysis techniques provide predictive capabilities with respect to real-time resource allocation and support vector optimization measures for identifying underperforming channels. Implementation in multiple courses of pharmaceutical marketing shows huge improvements in performance with an average increase of 42.7% on ROI through dynamic reinforcement learning-based resource allocation methods. The framework contains privacy-preserving federated learning methods which ensure regulatory compliance and yet allow comprehensive analytics across health datasets. Finally, the robustness of the methodology is assured through rigorous methodologies like in-context meta-learning and counterfactual analysis, which confirm steady performance across very different therapeutic areas and geographical markets. This particular piece of work is unusual because it combines mechanisms for anomaly detection with techniques for generating interpretable solutions. Marketers in pharmaceuticals thus receive clear optimization suggestions that do not compromise accountability.